PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
46.8% below 52-week high
20.27
16.6652W Low
38.1152W High
1 Week
15.8% below 1-week high
18.901W Low
24.071W High
PROCEPT BioRobotics Corporation - Common Stock (PRCT) traded between $16.66 and $38.11 over the past 52 weeks and last traded at $20.27, 46.8% below its 52-week high. Over the past week it ranged between $18.90 and $24.07.
Past 12 Months
1W
+$1.07
1M
+$2.76
3M
+$0.24
6M
-$5.17
YTD
-$10.49
1Y
-$11.34
PRCT was -35.9% over the past year, -20.3% over six months, -34.1% year to date, +5.6% in the last week.
12 Months vs Market
PRCT
DIA
SPY
QQQ
IWM
Over the past 12 months PRCT returned -35.9% versus DIA (Dow) +8.7%, SPY (S&P 500) +8.2%, QQQ (Nasdaq 100) +3.8% and IWM (Russell 2000) +10.7%.
Volume & Liquidity
2.45× 3-mo avg
Today 3,108,226
3-mo avg 1.3M
1W
1M
3M
6M
YTD
1Y
PRCT most recently traded 3,108,226 shares against a 3-month average daily volume of 1.3M. More NewsRead MoreFrequently Asked QuestionsIs PROCEPT BioRobotics Corporation - Common Stock publicly traded?
Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.
What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?
PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?
The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market
What is the current price of PROCEPT BioRobotics Corporation - Common Stock?
The current price of PROCEPT BioRobotics Corporation - Common Stock is 20.27
When was PROCEPT BioRobotics Corporation - Common Stock last traded?
The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 11/05/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|